Abstract:The title compound N-((3-(2-nitrophenyl) propanoyl)oxy)-N-phenylbenzamide (C22H18N2O5, M-r = 390.38) was synthesized with nitrobenzene as the starting materials and structurally characterized by H-1 NMR, C-13 NMR, IR, H RMS(E-SI) and single-crystal X-ray diffraction. The crystalline structure of the title compound was studied in detail. The single-crystal X-ray diffraction revealed that the compound crystallizes in monoclinic, space group P2(1)/n, with a = 14.4481(7), b = 8.0089(5), c = 16.6808(9) angstrom, alpha = 90.00(5), beta = 100.069(5), gamma = 90.00(5)degrees, M-r = 390.38, V = 1900.46(18) angstrom(3), Z = 4, D-c = 1.364 g/cm(-3), mu = 0.098, F(000) = 816.0, the final R = 0.0530 and wR = 0.1141 for 2525 observed reflections (I > 2 sigma(I)), R(all data) = 0.0813, wR(all data) = 0.1335, completeness to theta of 26.020 is 99.8% and GOF = 1.085. The crystal structure contains three branched chains with its center placed at the midpoint of N. The phenyl ring (C(8)similar to C(13)) makes a dihedral angle of 83.5(1) degrees C with the phenyl ring (C(1)similar to C(6)), and 80.5(1) degrees C with the nitro-substituted benzene ring (C(17)similar to C(22)), indicating that the three rings are not coplanar. Hydrogen bonds (C(10)-H(10)center dot center dot center dot O(3)), (C(15)-H(15B)center dot center dot center dot O(4) and C(16)-H(16B)center dot center dot center dot O(4)) together with pi-pi stacking interactions stabilize the structure of the molecule. The preliminary biological test shows that the title compound has good antitumor activity against A549 in vitro with the IC50 value of 3.17 mu mol.

Synthesis and Crystal Structure of （S）-Ethyl-2-（2-methoxy-phenylsulfenamido）-3-（1h-indol-3-yl）propanoate

Syntheses and Crystal Structures of (S)-Methyl-2-(4-r-phenylsulfonamido)-3-(1h-indol-3-yl)propanoate (R = H (1) and Cl (2))

Syntheses and crystal structures of (S)-methyl 2-(4-R-phenylsulfonamido)- 3(1H-indol-3-yl)propanoate (R=H (1) and Cl (2))

Synthesis and Crystal Structure Characterization of (1R,2R,3R,5S)-3-(3-chlorophenyl)-1-hydroxy-2-methyl-6-phenyl-8-oxa-6-azabicyclo[3.2.1]octan-7-one

Synthesis and Crystal Structure of 3-Chloro- N -(2-Chloro-5-(1,3-dioxo-4,5,6,7-tetrahydro-1h-isoindol-2(3h)-yl)-4-fluorophenyl)-2,2-dimethylpropanamide

(S)-2-(1h-imidazol-1-yl)-3-phenylpropanol

2-(4,6-Dimethoxypyrimidin-2-ylsulfanyl)-N-phenylbenzamide

Synthesis and Crystal Structure of N-Propyl-4-[2-(4,6- Dimethoxypyrimidin-2-yloxy)benzylamino] Benzoate

Synthesis, Bioactivity and Crystal Structure Analysis of Diisopropyl[(4-Cyanopyrazol-3-Ylamino)(2-Hydroxyl-Phenyl)Methyl]Phosphon Ate

Study on Crystal Structure of 1-(2,4-dichlorobenzyl)-1h-indazole-3-carboxylic Acid

Synthesis, crystal structure, Hirshfeld surface analyses, and DFT studies of ( S )-2-(3,5-di‐tert‐butyl‐4-hydroxyphenyl)-3,3-diethoxy-1-phenylpropan-1-one

Synthesis and Crystal Structure of (S)-N-(hexahydro-2-oxo-1h-azepin-3-yl)-3-phenyl-2-propenamide

Synthesis, Crystal Structure and Antibacterial Activity of (2E,3E)-N-1,N-2-Bis(2,3,4-trimethoxy-6-methylbenzylidene)ethane-1,2-diamine

Synthesis and Crystal Structure of N-（（3-（2-nitrophenyl） Propanoyl）oxy）-N-phenylbenzamide

Synthesis, Crystal, Calculated Structure and Biological Activity of N-((6-Bromo-2-Methoxyquinolin-3-Yl)(Phenyl)Methyl)-N-(1-Adamantyl)-3-(Di Methylamino) Propanamide

Synthesis And Crystal Structure Of Ethyl-5-Amino-1-(5-Methyl-1-Phenyl-4-Pyrazolyl)Carbonyl]-3-Methylsulfany L-1h-Pyrazole-4-Carboxylate

(R)-3-hydroxy-n,n-dimethyl-3-(2-thienyl)-propanamine

Synthesis And Crystal Structure Of Methyl (Z)-2-Hydroxy-3-Benzoylpropenoate

Synthesis and Crystal Structure of 1 '-Methyl-4 '-(4-chlorophenyl)-1h-indole-3-spiro-2 '-Pyrrolidine-3 '-Spiro-4 ''-(2 ''-Phenyloxazole)-2,5 ''(3h,4 '' H)-Dione

3-[2-(N,n-diethylamino)glyoxyloyl]-1h-indol-4-yl Acetate Monohydrate

Synthesis, Configuration Judgment and Potentiation Activity of (2S,3S,E)-4-(3,4-Dihydroxybenzylidene)-3-(3,4-dihydroxyphenyl)-5-oxotetrahydrofuran-2-carboxylic Acid